Gian Piero Reverberi Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gian Piero Reverberi.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gian Piero Reverberi. Gian Piero Reverberi is SVP & Chief Commercial Officer in Vanda Pharmaceuticals Inc. ($VNDA) and SVP, Acting CCO & GM Europe in Vanda Pharmaceuticals Inc. ($VNDA) and SVP, General Manager Europe in Vanda Pharmaceuticals Inc. ($VNDA).
Latest Insider Trading Transactions of Gian Piero Reverberi
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 04 2020 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP & Chief Commerc ... | Sell | S | 10.18 | 1,450 | 14,755 | 165,384 | 166.8 K to 165.4 K (-0.87 %) |
| Jan 06 2020 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP & Chief Commerc ... | Sell | S | 16.06 | 1,155 | 18,551 | 166,834 | 168 K to 166.8 K (-0.69 %) |
| Mar 04 2019 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP & Chief Commerc ... | Sell | S | 19.92 | 443 | 8,823 | 167,989 | 168.4 K to 168 K (-0.26 %) |
| Mar 04 2019 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP & Chief Commerc ... | Sell | S | 20.17 | 438 | 8,832 | 168,432 | 168.9 K to 168.4 K (-0.26 %) |
| Mar 01 2019 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP & Chief Commerc ... | Option Exercise | A | 20.62 | 70,000 | 1,443,400 | 70,000 | |
| Mar 01 2019 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP & Chief Commerc ... | Grant | A | 0.00 | 30,000 | 0 | 168,870 | 138.9 K to 168.9 K (+21.60 %) |
| Jan 04 2019 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP & Chief Commerc ... | Sell | S | 26.94 | 530 | 14,276 | 138,870 | 139.4 K to 138.9 K (-0.38 %) |
| Jan 04 2019 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP & Chief Commerc ... | Sell | S | 26.28 | 600 | 15,767 | 139,400 | 140 K to 139.4 K (-0.43 %) |
| Jan 04 2018 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP & Chief Commerc ... | Option Exercise | M | 0.00 | 7,500 | 0 | 15,000 | |
| Jan 04 2018 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP & Chief Commerc ... | Option Exercise | M | 0.00 | 12,500 | 0 | 25,000 | |
| Jan 04 2018 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP & Chief Commerc ... | Buy | M | 0.00 | 7,500 | 0 | 110,000 | 102.5 K to 110 K (+7.32 %) |
| Jan 04 2018 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP & Chief Commerc ... | Buy | M | 0.00 | 12,500 | 0 | 87,500 | 75 K to 87.5 K (+16.67 %) |
| Mar 03 2017 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP & Chief Commerc ... | Option Exercise | A | 14.50 | 70,000 | 1,015,000 | 70,000 | |
| Mar 03 2017 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP & Chief Commerc ... | Grant | A | 0.00 | 30,000 | 0 | 50,000 | 20 K to 50 K (+150.00 %) |
| Jan 05 2017 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP & Chief Commerc ... | Option Exercise | M | 0.00 | 7,500 | 0 | 22,500 | |
| Jan 05 2017 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP & Chief Commerc ... | Option Exercise | M | 0.00 | 12,500 | 0 | 37,500 | |
| Jan 05 2017 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP & Chief Commerc ... | Buy | M | 0.00 | 7,500 | 0 | 20,000 | 12.5 K to 20 K (+60.00 %) |
| Jan 05 2017 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP & Chief Commerc ... | Buy | M | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
| Feb 17 2016 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP, Acting CCO & G ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
| Feb 17 2016 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP, Acting CCO & G ... | Option Exercise | A | 7.94 | 70,000 | 555,800 | 70,000 | |
| Sep 09 2015 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP, General Manage ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
| Sep 09 2015 | VNDA | Vanda Pharmaceutic ... | Reverberi Gian Piero | SVP, General Manage ... | Option Exercise | A | 12.68 | 150,000 | 1,902,000 | 150,000 |
Page: 1